Ana Maria Rodrigues1, Maria João Gregório2, Rute Dinis Sousa3, Sara S Dias4, Maria José Santos5, Jorge M Mendes6, Pedro Simões Coelho6, Jaime C Branco7, Helena Canhão8. 1. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa; Sociedade Portuguesa de Reumatologia. Lisboa; Rheumatology Research Unit. Instituto de Medicina Molecular. Lisboa; EpiSaúde - Associação Científica. Évora. Portugal. 2. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa. EpiSaúde - Associação Científica. Évora. Faculdade de Ciências da Nutrição e Alimentação. Universidade do Porto. Porto. Programa Nacional para a Promoção da Alimentação Saudável. Direção-Geral da Saúde. Lisboa. Portugal. 3. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa. EpiSaúde - Associação Científica. Évora. Portugal. 4. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa. EpiSaúde - Associação Científica. Évora. Unidade de Investigação em Saúde. Escola Superior de Saúde. Instituto Politécnico de Leiria. Leiria. Portugal. 5. Sociedade Portuguesa de Reumatologia. Lisboa. Rheumatology Research Unit. Instituto de Medicina Molecular. Lisboa. Hospital Garcia de Orta. Almada. Portugal. 6. NOVA Information Management School. Universidade Nova de Lisboa. Lisboa. Portugal. 7. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa. Sociedade Portuguesa de Reumatologia. Lisboa. EpiSaúde - Associação Científica. Évora. Serviço de Reumatologia. Centro Hospitalar Lisboa Ocidental. Hospital Egas Moniz. Lisboa. Portugal. 8. EpiDoC Unit. Centro de Estudos de Doenças Crónicas. NOVA Medical School. Universidade Nova de Lisboa. Lisboa. Sociedade Portuguesa de Reumatologia. Lisboa. EpiSaúde - Associação Científica. Évora. Escola Nacional de Saúde Pública. Universidade Nova de Lisboa. Lisboa. Portugal.
Abstract
INTRODUCTION: Portuguese adults have a long lifespan, but it is unclear whether they live a healthy life in their final years. We aimed to determine the prevalence of multimorbidity and characterize lifestyle and other health outcomes among older Portuguese adults. MATERIAL AND METHODS: We performed a cross-sectional evaluation of 2393 adults, aged 65 and older, during the second wave of follow-up of the EpiDoC cohort, a population-based study involving long-term follow-up of a representative sample of the Portuguese population. Subjects completed a structured questionnaire during a telephone interview. Socioeconomic, demographic, lifestyle behaviours, chronic diseases, and health resources consumption were assessed. Cluster analysis was done to identify dietary patterns. Descriptive and analytic analysis was performed to estimate multimorbidity prevalence and its associated factors. RESULTS: Multimorbidity prevalence among older adults was 78.3%, increased with age strata (72.8% for 65 - 69 years to 83.4% for ≥ 80 years), and was highest in Azores (84.9%) and Alentejo (83.6%). The most common chronic diseases were hypertension (57.3%), rheumatic disease (51.9%), hypercholesterolemia (49.4%), and diabetes (22.7%). Depression symptoms were frequent (11.8%) and highest in the oldest strata. The mean health-related quality of life (EQ-5D-3L) score was 0.59 ± 0.38. Hospitalization in the previous 12 months was reported by 25.8% of individuals. Overall, 66.6% of older adults were physically inactive. 'Fruit and vegetables dietary pattern' was followed by 85.4% of individuals; however, regional inequalities were found (69% in Azores). Obesity prevalence was 22.3% overall and was highest among Azoreans (33%). CONCLUSION: The high prevalence of multimorbidity, combined with unhealthy lifestyle behaviours, suggests that the elderly populationconstitutes a vulnerable group warranting dedicated intervention.
INTRODUCTION: Portuguese adults have a long lifespan, but it is unclear whether they live a healthy life in their final years. We aimed to determine the prevalence of multimorbidity and characterize lifestyle and other health outcomes among older Portuguese adults. MATERIAL AND METHODS: We performed a cross-sectional evaluation of 2393 adults, aged 65 and older, during the second wave of follow-up of the EpiDoC cohort, a population-based study involving long-term follow-up of a representative sample of the Portuguese population. Subjects completed a structured questionnaire during a telephone interview. Socioeconomic, demographic, lifestyle behaviours, chronic diseases, and health resources consumption were assessed. Cluster analysis was done to identify dietary patterns. Descriptive and analytic analysis was performed to estimate multimorbidity prevalence and its associated factors. RESULTS: Multimorbidity prevalence among older adults was 78.3%, increased with age strata (72.8% for 65 - 69 years to 83.4% for ≥ 80 years), and was highest in Azores (84.9%) and Alentejo (83.6%). The most common chronic diseases were hypertension (57.3%), rheumatic disease (51.9%), hypercholesterolemia (49.4%), and diabetes (22.7%). Depression symptoms were frequent (11.8%) and highest in the oldest strata. The mean health-related quality of life (EQ-5D-3L) score was 0.59 ± 0.38. Hospitalization in the previous 12 months was reported by 25.8% of individuals. Overall, 66.6% of older adults were physically inactive. 'Fruit and vegetables dietary pattern' was followed by 85.4% of individuals; however, regional inequalities were found (69% in Azores). Obesity prevalence was 22.3% overall and was highest among Azoreans (33%). CONCLUSION: The high prevalence of multimorbidity, combined with unhealthy lifestyle behaviours, suggests that the elderly populationconstitutes a vulnerable group warranting dedicated intervention.
Entities:
Keywords:
Aging; Comorbidity; Delivery of Health Care; Outcome Assessment (Health Care); Portugal; Quality of Life
Authors: Simone G Fernandes; Ana M Rodrigues; Carla Nunes; Osvaldo Santos; Maria J Gregório; Rute Dinis de Sousa; Sara Dias; Helena Canhão Journal: Front Med (Lausanne) Date: 2018-07-12
Authors: Sara Simões Dias; Ana Maria Rodrigues; Maria João Gregório; Rute Dinis de Sousa; Jaime Cunha Branco; Helena Canhão Journal: Int J Epidemiol Date: 2018-12-01 Impact factor: 7.196
Authors: Gisela M Oliveira; Diogo Guedes Vidal; Maria Pia Ferraz; José Manuel Cabeda; Manuela Pontes; Rui Leandro Maia; José Manuel Calheiros; Esmeralda Barreira Journal: Int J Environ Res Public Health Date: 2019-10-25 Impact factor: 3.390
Authors: Ana C Moreira; Maria Jose Teles; Tânia Silva; Clara M Bento; Inês Simões Alves; Luisa Pereira; João Tiago Guimarães; Graça Porto; Pedro Oliveira; Maria Salomé Gomes Journal: Viruses Date: 2021-12-10 Impact factor: 5.048